High GHR mRNA expression in ER−ve breast cancer patients (n = 671) was associated with a significantly poor survival probability (HR−1.26; p = 0.041) compared to ER−ve breast cancer patients with low expression of GHR (Fig. 1g). This evidence concerns the gene GHR and breast carcinoma.